Compare KLTR & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KLTR | ANIK |
|---|---|---|
| Founded | 2006 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.0M | 200.9M |
| IPO Year | 2021 | 1996 |
| Metric | KLTR | ANIK |
|---|---|---|
| Price | $1.35 | $20.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 206.0K | 71.4K |
| Earning Date | 05-08-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.90 | ★ 80.16 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $180,854,000.00 | $112,819,000.00 |
| Revenue This Year | $2.96 | $5.98 |
| Revenue Next Year | $4.96 | $7.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1.20 | N/A |
| 52 Week Low | $1.06 | $8.67 |
| 52 Week High | $2.05 | $22.88 |
| Indicator | KLTR | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 34.88 | 50.28 |
| Support Level | $1.32 | $20.13 |
| Resistance Level | $1.38 | $22.70 |
| Average True Range (ATR) | 0.05 | 0.62 |
| MACD | -0.02 | -0.18 |
| Stochastic Oscillator | 8.50 | 32.00 |
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.